Cargando…
COVID-19 et marqueurs immunologiques pertinents
In its severe form, corona virus disease-19 (COVID-19) is characterized by various immunological abnormalities, dominated by massive pro-inflammatory cytokine and chemokine release, such as IL-6, TNF-α, IL-1b, IFN-y and monocyte chemoattractant protein-1 (MCP-1), associated with T CD3, T CD4 and T C...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356923/ https://www.ncbi.nlm.nih.gov/pubmed/34422163 http://dx.doi.org/10.11604/pamj.2021.39.40.23481 |
_version_ | 1783737035245223936 |
---|---|
author | Admou, Brahim |
author_facet | Admou, Brahim |
author_sort | Admou, Brahim |
collection | PubMed |
description | In its severe form, corona virus disease-19 (COVID-19) is characterized by various immunological abnormalities, dominated by massive pro-inflammatory cytokine and chemokine release, such as IL-6, TNF-α, IL-1b, IFN-y and monocyte chemoattractant protein-1 (MCP-1), associated with T CD3, T CD4 and T CD8 lymphopenia. These two abnormalities are significantly associated with COVID-19 acute severe respiratory syndrome. Conversely, these markers decrease during the favorable course of the disease. Coupled with other biological parameters such as leukopenia, increased level of CRP (C Reactive Protein), ferritin and D-dimers, high levels of IL-6 with CD4 and CD8 T cell lymphopenia may be considered as criteria of disease severity, justifying a rapid admission to the intensive care unit, and are also useful for patient monitoring. |
format | Online Article Text |
id | pubmed-8356923 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The African Field Epidemiology Network |
record_format | MEDLINE/PubMed |
spelling | pubmed-83569232021-08-20 COVID-19 et marqueurs immunologiques pertinents Admou, Brahim Pan Afr Med J Commentary In its severe form, corona virus disease-19 (COVID-19) is characterized by various immunological abnormalities, dominated by massive pro-inflammatory cytokine and chemokine release, such as IL-6, TNF-α, IL-1b, IFN-y and monocyte chemoattractant protein-1 (MCP-1), associated with T CD3, T CD4 and T CD8 lymphopenia. These two abnormalities are significantly associated with COVID-19 acute severe respiratory syndrome. Conversely, these markers decrease during the favorable course of the disease. Coupled with other biological parameters such as leukopenia, increased level of CRP (C Reactive Protein), ferritin and D-dimers, high levels of IL-6 with CD4 and CD8 T cell lymphopenia may be considered as criteria of disease severity, justifying a rapid admission to the intensive care unit, and are also useful for patient monitoring. The African Field Epidemiology Network 2021-05-17 /pmc/articles/PMC8356923/ /pubmed/34422163 http://dx.doi.org/10.11604/pamj.2021.39.40.23481 Text en Copyright: Brahim Admou et al. https://creativecommons.org/licenses/by/4.0/The Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Admou, Brahim COVID-19 et marqueurs immunologiques pertinents |
title | COVID-19 et marqueurs immunologiques pertinents |
title_full | COVID-19 et marqueurs immunologiques pertinents |
title_fullStr | COVID-19 et marqueurs immunologiques pertinents |
title_full_unstemmed | COVID-19 et marqueurs immunologiques pertinents |
title_short | COVID-19 et marqueurs immunologiques pertinents |
title_sort | covid-19 et marqueurs immunologiques pertinents |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356923/ https://www.ncbi.nlm.nih.gov/pubmed/34422163 http://dx.doi.org/10.11604/pamj.2021.39.40.23481 |
work_keys_str_mv | AT admoubrahim covid19etmarqueursimmunologiquespertinents |